Effects of rapamycin on apoptosis of rheumatoid synovial cells

Clinical and Experimental Immunology

Volumn 108, Issue 2, 1997, Pages 199-203

  Migita, K ^a   Eguchi, K ^a   Ichinose, Y ^a   Kawabe, Y ^a   Tsukada, T ^a   Aoyagi, T ^b   Nagataki, S ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b Ureshino Medical Center   (Japan)

Author keywords

bcl 2; Fas antigen; rapamycin; rheumatoid arthritis; synovium apoptosis

Indexed keywords

ANTIRHEUMATIC AGENT; AUROTHIOMALATE; BUCILLAMINE; DNA FRAGMENT; FAS ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; PENICILLAMINE; PLATELET DERIVED GROWTH FACTOR; PROTEIN BCL 2; RAPAMYCIN; SALAZOSULFAPYRIDINE;

ADULT; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSIS; DRUG EFFECT; DRUG THERAPY; ETIOLOGY; FEMALE; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVECTOMY; SYNOVIOCYTE;

EID: 0031006244     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-1002.x     Document Type: Article

References (33)

1. Cohen JJ, Duke RC, Fadok VA, Sellins KS. Apoptosis and programmed cell death in immunity. Ann Rev Immunol 1992; 10:267-93.
2. Thompson CB. Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-62.
3. Hamilton JA. Hypothesis: in vitro evidence for the invasive and tumor-like properties of rheumatoid pannus. J Rheumatol 1983; 10:845-51.
4. Lafyatis R, Rammers EF, Roberts AB, Yocum DE, Sporn MB, Wider RL. Anchorage-independent growth of synoviocytes from arthritis and normal joints. J Clin Invest 1989; 83:1267-76.
5. Nakajima T, Aono H, Hasunuma T, Yamamoto K, Shirai T, Hirohata K, Nishioka K. Apoptosis and functional Fas antigen in rheumatoid arthritis. Arthritis Rheum 1995; 38:485-91.
6. Firestein GS, Yeo M, Zvaifler N. Apoptosis in rheumatoid arthritis synovium. J Clin Invest 1995; 96:1631-8.
7. Itoh N, Yonehara S, Ishii A et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-43.
8. Nagata S, Goldstein P. The Fas death factor. Science 1995; 267:1449-56.
9. Fisher GH, Rosenberg FJ, Strauss SF et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 1995; 81:935-46.
10. Nagata S, Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol Today 1995; 16:39-43.
11. Tsujimoto Y, Cossman J, Jaffe E, Croce C. Involvement of the bcl-2 gene in human follicular lymphoma. Science 1985; 228:1440-3.
12. Sentman CL, Schulter J, Hockenberg D, Kanagawa O, Korsmeyer SJ. BCL-2 inhibits multiple form of apoptosis but not negative selection in thymocytes. Cell 1992; 67:879-87.
13. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 241:1-6.
14. Otani H, Erdos M, Leonard WT. Tyrosine kinase(s) regulate apoptosis and bcl-2 expression in a growth factor-dependent cell line. J Biol Chem 1993; 168:22733-6.
15. Deng G, Podack E. Suppression of apoptosis in a cytotoxic T-cell line by interleukin 2-mediated gene transcription and deregulated expression of protooncogene bcl-2. Proc Natl Acad Sci USA 1993; 90:2189-93.
16. Miyazaki T, Lin Z-J, Kawahara A et al. Three distinct IL-2 signaling pathways mediated by bcl-2, C-myc and lck cooperate in haematopoietic cell proliferation. Cell 1995; 81:223-31.
17. Sehgal SN, Molnan-Kimber K, Ocain T, Weickman BM. Rapamycin: a novel immunosuppressive macrolide. Med Res Rev 1994; 14:1-22.
18. Schreiber SL. Chemistry and biology of the immunophilins and their immunosuppressive ligands. Science 1991; 251:283-7.
19. Morris RE. Rapamycin: FK506's fraternal twin or cousin? Immunol Tody 1991; 12:137-40.
20. Migita K, Eguchi K, Aoyagi T, Tsukada T, Tsuboi M, Kawabe Y, Nagataki S. The effects of the immunosuppressant rapamycin on the growth of rheumatoid arthritis (RA) synovial fibroblasts. Clin Exp Immunol 1996; 104:86-91.
21. Tsukada T, Eguchi K, Migita K et al. Transforming growth factor β1 induced apoptotic cell death in cultured human umbilical vein endothelial cells with down-regulated expression of bcl-2. Biochem Biophys Res Commun 1995; 210:1076-82.
22. Migita K, Eguchi K, Kawabe Y, Mizokami A, Tsukada T, Nagataki S. Prevention of anti-CD3 monoclonal antibody-induced thymic apoptosis by protein tyrosine kinase inhibitors. J Immunol 1994; 154:3457-65.
23. Vezina C, Kudeleski A, Sehgal SN. Rapamycin (AY-22989) a new antifungal antibiotic I. Toxonomy producing streptomycete and isolation of active principle. J Antibiot 1975; 28:721-6.
24. Sehgal SN, Baker H, Vezinac C. Rapamycin (AY-22989), a new antifungal antibiotic II. Fermentation, isolation and characterization. J Antibiot 1975; 28:727-32.
25. Chung J, Dumont FL, Starauch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanisms of suppression of murine T cell activation by the related macrolidcs FK506 and rapamycin. J Immunol 1990; 144:251-8.
26. Cao W, Mohacsi P, Shorthouse R, Pratt R, Morris RE. Effect of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Transplantation 1995; 59:390-5.
27. Itoh N, Tsujimoto Y, Nagata S. Effect of Bcl-2 on Fas antigen-mediated cell death. J Immunol 1993; 151:621-7.
28. Memon SA, Moreno MB, Petrack D, Zacharchuks CM. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J Immunol 1995; 155:4644-52.
29. Terada N, Lucas JJ, Szepesi A, Franklin RA, Domenico J, Gelfand EW. Rapamycin blocks cell cycle progression of activated T cells prior to events characteristic of the middle to late G1 phase of the cycle. J Cell Physiol 1993; 154:7-15.
30. Nunez G, Merino R, Grillot D, Gonzalez-Garcia. Bcl-1 and Bcl-x regulatory switches for lymphoid death and survival. Immunol Today 1994; 15:582-7.
31. Reed C. Bcl-2 and the regulation of programmed cell death J Cell Biol 1996; 124:1-6.
32. Suda T, Takahashi T, Goldstein P, Nagata S. Molecular cloning and expression of Fas ligand. A novel member of the tumor necrosis factor family. Cell 1993; 75:1169-78.
33. Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, Nakao K, Nagata S. Expression of the Fas ligland in T-cell lineage. J Immunol 1995; 154:3806-13.